211 related articles for article (PubMed ID: 29268144)
1. Multifunctional hybrid micelles with tunable active targeting and acid/phosphatase-stimulated drug release for enhanced tumor suppression.
Liu X; Li Y; Tan X; Rao R; Ren Y; Liu L; Yang X; Liu W
Biomaterials; 2018 Mar; 157():136-148. PubMed ID: 29268144
[TBL] [Abstract][Full Text] [Related]
2. Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.
Xu Y; Lu Y; Wang L; Lu W; Huang J; Muir B; Yu J
Colloids Surf B Biointerfaces; 2016 May; 141():318-326. PubMed ID: 26874117
[TBL] [Abstract][Full Text] [Related]
3. Improved therapeutic effect of DOX-PLGA-PEG micelles decorated with bivalent fragment HAb18 F(ab')(2) for hepatocellular carcinoma.
Jin C; Qian N; Zhao W; Yang W; Bai L; Wu H; Wang M; Song W; Dou K
Biomacromolecules; 2010 Sep; 11(9):2422-31. PubMed ID: 20831277
[TBL] [Abstract][Full Text] [Related]
4. A54 Peptide Modified and Redox-Responsive Glucolipid Conjugate Micelles for Intracellular Delivery of Doxorubicin in Hepatocarcinoma Therapy.
Liu N; Tan Y; Hu Y; Meng T; Wen L; Liu J; Cheng B; Yuan H; Huang X; Hu F
ACS Appl Mater Interfaces; 2016 Dec; 8(48):33148-33156. PubMed ID: 27934140
[TBL] [Abstract][Full Text] [Related]
5. Tumor cells-specific targeting delivery achieved by A54 peptide functionalized polymeric micelles.
Du YZ; Cai LL; Liu P; You J; Yuan H; Hu FQ
Biomaterials; 2012 Dec; 33(34):8858-67. PubMed ID: 22959183
[TBL] [Abstract][Full Text] [Related]
6. In vivo pharmacokinetics, biodistribution and the anti-tumor effect of cyclic RGD-modified doxorubicin-loaded polymers in tumor-bearing mice.
Wang C; Li Y; Chen B; Zou M
Colloids Surf B Biointerfaces; 2016 Oct; 146():31-8. PubMed ID: 27244048
[TBL] [Abstract][Full Text] [Related]
7. Tumor-preferential sustained drug release enhances antitumor activity of block copolymer micelles.
Ponta A; Bae Y
J Drug Target; 2014 Aug; 22(7):619-28. PubMed ID: 24766185
[TBL] [Abstract][Full Text] [Related]
8. Glycyrrhetinic Acid-Mediated Polymeric Drug Delivery Targeting the Acidic Microenvironment of Hepatocellular Carcinoma.
Zhang J; Zhang M; Ji J; Fang X; Pan X; Wang Y; Wu C; Chen M
Pharm Res; 2015 Oct; 32(10):3376-90. PubMed ID: 26148773
[TBL] [Abstract][Full Text] [Related]
9. MRI-visible and pH-sensitive micelles loaded with doxorubicin for hepatoma treatment.
Li B; Cai M; Lin L; Sun W; Zhou Z; Wang S; Wang Y; Zhu K; Shuai X
Biomater Sci; 2019 Mar; 7(4):1529-1542. PubMed ID: 30681081
[TBL] [Abstract][Full Text] [Related]
10. Folate-functionalized polymeric micelle as hepatic carcinoma-targeted, MRI-ultrasensitive delivery system of antitumor drugs.
Hong G; Yuan R; Liang B; Shen J; Yang X; Shuai X
Biomed Microdevices; 2008 Oct; 10(5):693-700. PubMed ID: 18350380
[TBL] [Abstract][Full Text] [Related]
11. Glycyrrhetinic acid-decorated and reduction-sensitive micelles to enhance the bioavailability and anti-hepatocellular carcinoma efficacy of tanshinone IIA.
Chen F; Zhang J; He Y; Fang X; Wang Y; Chen M
Biomater Sci; 2016 Jan; 4(1):167-82. PubMed ID: 26484363
[TBL] [Abstract][Full Text] [Related]
12. Disease-directed design of biodegradable polymers: Reactive oxygen species and pH-responsive micellar nanoparticles for anticancer drug delivery.
Leong J; Chin W; Ke X; Gao S; Kong H; Hedrick JL; Yang YY
Nanomedicine; 2018 Nov; 14(8):2666-2677. PubMed ID: 30017961
[TBL] [Abstract][Full Text] [Related]
13. Cationic drug-based self-assembled polyelectrolyte complex micelles: Physicochemical, pharmacokinetic, and anticancer activity analysis.
Ramasamy T; Poudel BK; Ruttala H; Choi JY; Hieu TD; Umadevi K; Youn YS; Choi HG; Yong CS; Kim JO
Colloids Surf B Biointerfaces; 2016 Oct; 146():152-60. PubMed ID: 27318960
[TBL] [Abstract][Full Text] [Related]
14. RGD peptide-mediated chitosan-based polymeric micelles targeting delivery for integrin-overexpressing tumor cells.
Cai LL; Liu P; Li X; Huang X; Ye YQ; Chen FY; Yuan H; Hu FQ; Du YZ
Int J Nanomedicine; 2011; 6():3499-508. PubMed ID: 22282676
[TBL] [Abstract][Full Text] [Related]
15. Cell microenvironment-controlled antitumor drug releasing-nanomicelles for GLUT1-targeting hepatocellular carcinoma therapy.
Guo Y; Zhang Y; Li J; Zhang Y; Lu Y; Jiang X; He X; Ma H; An S; Jiang C
ACS Appl Mater Interfaces; 2015 Mar; 7(9):5444-53. PubMed ID: 25686400
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin loaded pH-sensitive micelle: antitumoral efficacy against ovarian A2780/DOXR tumor.
Kim D; Lee ES; Park K; Kwon IC; Bae YH
Pharm Res; 2008 Sep; 25(9):2074-82. PubMed ID: 18449626
[TBL] [Abstract][Full Text] [Related]
17. Hybrid polymeric micelles based on bioactive polypeptides as pH-responsive delivery systems against melanoma.
Wang QM; Gao Z; Liu S; Fan B; Kang L; Huang W; Jin M
Biomaterials; 2014 Aug; 35(25):7008-21. PubMed ID: 24875757
[TBL] [Abstract][Full Text] [Related]
18. Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells.
Zhong Y; Yang W; Sun H; Cheng R; Meng F; Deng C; Zhong Z
Biomacromolecules; 2013 Oct; 14(10):3723-30. PubMed ID: 23998942
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin.
Xiong XB; Ma Z; Lai R; Lavasanifar A
Biomaterials; 2010 Feb; 31(4):757-68. PubMed ID: 19818492
[TBL] [Abstract][Full Text] [Related]
20. Cleavable Multifunctional Targeting Mixed Micelles with Sequential pH-Triggered TAT Peptide Activation for Improved Antihepatocellular Carcinoma Efficacy.
Zhang J; Zheng Y; Xie X; Wang L; Su Z; Wang Y; Leong KW; Chen M
Mol Pharm; 2017 Nov; 14(11):3644-3659. PubMed ID: 28994600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]